Blueprint Medicines Corporation (NASDAQ:BPMC) is one of the best biotech stocks to invest in now. On June 12, Blueprint Medicines announced new data reinforcing the sustained clinical efficacy and ...

(Sharecast News) - Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic ...

Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic test to be marketed ...

North West Anglia Foundation NHS Trusts' Peterborough City Hospital implements the Genedrive® CYP2C19-ID Kit for routine clinical use genedrive plc (AIM: GDR), the point of care pharmacogenetic ...

KOZHIKODE: With reports of drug abuse among school students making headlines, concerned parents are increasingly relying on multi-panel drug test kits to monito ...

LONDON - Genedrive plc (AIM: GDR), a company specializing in point of care pharmacogenetic testing, has announced the publication of a clinical study in the Journal of Molecular Biology, showcasing ...